These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3618619)

  • 1. Particle-size distribution of bitolterol mesylate solution delivered by four compressed-air nebulizer devices.
    Hunke WA; Yu AB
    Am J Hosp Pharm; 1987 Jun; 44(6):1392-6. PubMed ID: 3618619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparison of the circulaire and AeroTee to a traditional nebulizer T-piece with corrugated tubing.
    Piper SD
    Respir Care; 2000 Mar; 45(3):313-9. PubMed ID: 10771800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Output and aerosol properties of 5 nebulizer/compressor systems with arformoterol inhalation solution.
    Bauer A; McGlynn P; Bovet LL; Mims PL; Curry LA; Hanrahan JP
    Respir Care; 2009 Oct; 54(10):1342-7. PubMed ID: 19796414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical nebulizer performance: effects of cascade impactor temperature.
    Zhou Y; Ahuja A; Irvin CM; Kracko DA; McDonald JD; Cheng YS
    Respir Care; 2005 Aug; 50(8):1077-82. PubMed ID: 16225713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of bronchodilator drug delivery by jet nebulization during pediatric mechanical ventilation.
    Di Paolo ER; Pannatier A; Cotting J
    Pediatr Crit Care Med; 2005 Jul; 6(4):462-9. PubMed ID: 15982436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.
    Pinnas JL; Bhatt BD; Campbell SC; Kemp JP; Tinkelman DG
    Chest; 1987 Apr; 91(4):533-9. PubMed ID: 3549173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of aerosol output from various nebulizer/compressor combinations.
    Reisner C; Katial RK; Bartelson BB; Buchmeir A; Rosenwasser LJ; Nelson HS
    Ann Allergy Asthma Immunol; 2001 May; 86(5):566-74. PubMed ID: 11379809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro study to investigate the use of a breath-actuated, small-volume, pneumatic nebulizer for the delivery of methacholine chloride bronchoprovocation agent.
    Mitchell JP; Nagel MW; Bates SL; Doyle CC
    Respir Care; 2003 Jan; 48(1):46-51. PubMed ID: 12556261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalation and deposition of nebulized sodium cromoglycate in two different particle size distributions in children with asthma.
    Nerbrink OL; Lindström M; Meurling L; Svartengren M
    Pediatr Pulmonol; 2002 Nov; 34(5):351-60. PubMed ID: 12357479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
    Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
    Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro deposition properties of nebulized formoterol fumarate: effect of nebulization time, airflow, volume of fill and nebulizer type.
    Okapo SO; Gupta J; Martinez E; Mark R
    Curr Med Res Opin; 2009 Apr; 25(4):807-16. PubMed ID: 19207092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) Respirator Solution.
    MacNeish CF; Meisner D; Thibert R; Kelemen S; Vadas EB; Coates AL
    Chest; 1997 Jan; 111(1):204-8. PubMed ID: 8996018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study of bitolterol mesylate in the treatment of conditions associated with reversible bronchospasm.
    Messina MS
    Adv Ther; 1995; 12(3):157-63. PubMed ID: 10155050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design principles of liquid nebulization devices currently in use.
    Rau JL
    Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bronchodilator responses with bitolterol mesylate solution with the use of two different nebulizer systems in asthma.
    Kemp JP; Pinnas JL; Tinkelman DG; Meltzer EO; Campbell SC; Orgel HA; Welch MJ; Mingo TS
    J Allergy Clin Immunol; 1986 Mar; 77(3):509-15. PubMed ID: 3950254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of some bronchodilator solutions during ultrasonic nebulization.
    Hunke WA; Katz E; Gorman WG
    Am J Hosp Pharm; 1982 Feb; 39(2):297-300. PubMed ID: 7058801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol.
    Kemp JP; Orgel HA; Grossman J; Reed CE; Tinkelman DG; Webb DR; Ziment I
    Ann Allergy; 1987 Jul; 59(1):17-20. PubMed ID: 3300436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.